Lucinity secures $17 million in its Series B round to fight financial crimes through AML. The company will utilize the funding accelerate growth and geographic coverage for its Human AI technology.
Our portfolio company, Garden, is joining forces with Incredibuild to enhance software delivery for development teams. Together, they plan to enable faster code-to-deployment across applications in the future.
Our portfolio company, PipeBio, has been acquired by Benchling. The acquisition brings together Benchling’s leadership in cloud-based R&D software with PipeBio’s expertise in high-throughput bioinformatics, driving future innovation in biologics discovery.
We invested in DataCrunch! DataCrunch is transforming the AI compute landscape by providing scalable, cost-efficient solutions from energy-efficient data centers in Iceland and Finland.